unc2025 and Melanoma

unc2025 has been researched along with Melanoma* in 1 studies

Other Studies

1 other study(ies) available for unc2025 and Melanoma

ArticleYear
Inhibition of MERTK Promotes Suppression of Tumor Growth in BRAF Mutant and BRAF Wild-Type Melanoma.
    Molecular cancer therapeutics, 2019, Volume: 18, Issue:2

    Molecularly-targeted agents have improved outcomes for a subset of patients with

    Topics: Adenine; Animals; Azetidines; c-Mer Tyrosine Kinase; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Female; GTP Phosphohydrolases; Humans; Melanoma; Membrane Proteins; Mice; Mutation; Phosphorylation; Piperazines; Piperidines; Proto-Oncogene Proteins B-raf; Signal Transduction; Vemurafenib

2019